Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1

Fig. 2

Sorafenib enhances DHA’s cytotoxicity in A2780 cells. a Cells were treated with Sorafenib and DHA for 48 h and cell viability was determined by the MTS assay (n = 3, mean ± SEM, *p < 0.01). b Bach1 was knocked down in A2780 cells using targeted siRNAs. Cells were treated with Sorafenib and DHA for 48 h and cell viability was determined by the MTS assay (n = 3, mean ± SEM, *p < 0.01)

Back to article page